Laser speckle flowgraphy may be useful in identifying eyes with normal-tension glaucoma

Article

Waveform changes in optic nerve head (ONH) blood flow as measured by laser speckle flowgraphy may be useful in differentiating healthy eyes from those with normal-tension glaucoma (NTG), according to the authors of a recent study.

Waveform changes in optic nerve head (ONH) blood flow as measured by laser speckle flowgraphy may be useful in differentiating healthy eyes from those with normal-tension glaucoma (NTG), according to the authors of a recent study published in Investigative Ophthalmology & Visual Science.

For this study, Yukihiro Shiga and fellow researchers at Tohoku University Graduate School of Medicine, Miyagi, Japan, included 61 eyes of 61 patients with NTG, and 21 eyes from age-matched healthy controls. NTG eyes were divided into three groups, based on the progression of visual field defects: mild (mean deviation [MD] > -6.0 dB), moderate (MD -6.0 to -12.0 dB), and severe (MD

Skew was found to be significantly lower in NTG eyes compared with controls (P

To access this study, click here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.